IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Minakem Acquires API Plant from AstraZeneca

9:59 AM MDT | May 29, 2009

Pharmaceutical intermediates and active pharma ingredients (API) manufacturer Minakem (Beuvry-la-Forêt, France) has completed the acquisition of a multi-purpose API plant at Dunkirk, France from AstraZeneca. Minakem says it has also signed a long-term contract with AstraZeneca to supply budesonide, omeprazole, and esomeprazole. Financial details of the deal were not disclosed. The deal brings Minakem significant manufacturing capabilities and raises its custom synthesis capacity, Minakem says. The increased capacity will also help to reduce API costs, the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa